Recently, we published that ICON had increased their expectations for earnings this year. Yesterday, PharmaTimes gave them the award Clinical Research Company of the Year.
The Chief Operating Officer, Alan Morgan, had this to say about the award:
"We are delighted with our success at the PharmaTimes awards, as it recognizes the outstanding contribution that our people have made to the overall success of the organization. ICON has established itself as a global service provider with an excellent level reputation for quality and service, which is down to the effort of our staff. We are very proud of the winners and all of our finalists."
For more information, click here.
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
January
(20)
- Drug CROs: Good Medicine for Investors
- Quintiles partners with India’s Apollo Hospitals G...
- Kendle expands in India
- Free Webinar: The Benefits of Establishing a Gover...
- Read the January Partnerships with CROs LinkedIn R...
- Project Management in the Life Sciences: Results f...
- Indigo BioSystems Successfully Tests First Globall...
- Problems in Patient Recruitment in Outsourced Clin...
- ICON annouced as the Clinical Research Company of ...
- Icon increased 2008 earnings
- IRBs are Overloaded with Adverse Events
- South Africa seeing less funding for clinical trials
- FDA Limits Interest in Clinical Trials
- India Expected to Draw More Clinical Trials by 2012
- Insurance and clinical trials
- RNCOS: India Most Economical Destination for Globa...
- Merck and PPD Partner in Outsourcing Deal
- Brazil is critical base for PPD's CROs efforts
- India Offers More Education for Clinical Research
- Ethical Guidelines in India
-
▼
January
(20)
No comments:
Post a Comment